Usuario:

1.1.1.1 Cursos a Nivel de Licenciatura

Por favor, utilice la liga Insertar nuevo registro para agregar registros, la liga Ver para verificar los datos, si se requiere algún cambio, presione la liga Editar; en caso de querer eliminar toda la información del registro, presione la liga Borrar. Al final presione el botón Aceptar o Confirmar para registrar los cambios

Página Anterior

Registro Anterior

Siguiente Registro

---

Clave	102659
Nombre del Modulo	1.1.1.1 Cursos a Nivel de Licenciatura
Tipo de Curso	Métodos cuantitativos
Trimestre Lectivo	10/P
Coeficiente de Participacion	I do some voluntary work http://xvedio.in.net/xvidoes/ xvidoes com Analysts on average forecast U.S. sales of sugammadex, ifapproved, to reach $663 million annually by 2018, according toReuters data. It would compete with Valeant PharmaceuticalsInternati
Numero de Horas	I do some voluntary work http://xvedio.in.net/xvidoes/ xvidoes com Analysts on average forecast U.S. sales of sugammadex, ifapproved, to reach $663 million annually by 2018, according toReuters data. It would compete with Valeant PharmaceuticalsInternati
Grupo	I do some voluntary work http://xvedio.in.net/xvidoes/ xvidoes com Analysts on average forecast U.S. sales of sugammadex, ifapproved, to reach $663 million annually by 2018, according toReuters data. It would compete with Valeant PharmaceuticalsInternati
Observaciones	I do some voluntary work http://xvedio.in.net/xvidoes/ xvidoes com Analysts on average forecast U.S. sales of sugammadex, ifapproved, to reach $663 million annually by 2018, according toReuters data. It would compete with Valeant PharmaceuticalsInternati
Descripcion	I do some voluntary work http://xvedio.in.net/xvidoes/ xvidoes com Analysts on average forecast U.S. sales of sugammadex, ifapproved, to reach $663 million annually by 2018, according toReuters data. It would compete with Valeant PharmaceuticalsInte
U.E.A.	TELEVISIÓN Y PROCESOS CULTURALES-PRODUCCIÓN AUDIOVISUAL II	323006
Número Económico	0
Fecha de registro	2019-05-22 19:47:18